共 143 条
[1]
Adithan C(2003)Allele and genotype frequency of CYP2C9 in Tamilnadu population Eur J Clin Pharmacol 59 707-709
[2]
Gerard N(2007)Genetic polymorphisms of drug-metabolizing enzymes CYP2D6, CYP2C9, CYP2C19 and CYP3A5 in the Greek population Fundam Clin Pharmacol 21 419-426
[3]
Vasu S(2005)A polymorphism in Blood 105 645-649
[4]
Balakrishnan R(1994) gene is associated with an inter-individual variability in the dose-anticoagulant effect of warfarin Mol Pharmacol 46 594-598
[5]
Shashindran CH(2007)Identification of a new genetic defect responsible for the polymorphism of ( Iran J Immunol 4 85-93
[6]
Krishnamoorthy R(2007))-mephenytoin metabolism in Japanese Int J Immunogenet 34 457-463
[7]
Arvanitidis K(2004)HLA class II genetic diversity in Arabs and Jews of Iran Tissue Antigens 64 581-587
[8]
Ragia G(2003)HLA class II similarities in Iranian Kurds and Azeris Eur J Clin Pharmacol 59 303-312
[9]
Iordanidou M(1994)Molecular analysis of HLA allele frequencies and haplotypes in Baloch of Iran compared with related populations of Pakistan Pharmacogenetics 4 285-299
[10]
Kyriaki S(2002)Polymorphisms of drug-metabolizing enzymes CYP2C9, CYP2C19, CYP2D6, CYP1A1, NAT2 and of P-glycoprotein in a Russian population Br J Clin Pharmacol 53 596-603